Discover Tenders by Modelling Pastes Sector

Find the most relevant tenders for Modelling Pastes. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Modelling Pastes tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Modelling Pastes tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Bosutinib L01Ea04 Within The Framework Of A So Called Open House Model

Deadline: 31 Aug 2026

Germany

Ref. No.: 8803968

EMD:Ref Document

Bid Value: Ref Document

125 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Timolol Brinzolamide Atc S01Ed67 Obg For The Period 01 11 2024 31 10 2026

Deadline: 05 Sep 2026

Germany

Ref. No.: 8801281

EMD:Ref Document

Bid Value: Ref Document

130 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Allergen Extract Of Various Origins Subcutaneous Syringes V01Aa02 V01Aa03 V01Aa05 For The Period 01 11 2024 31 10 2026

Deadline: 05 Sep 2026

Germany

Ref. No.: 8800167

EMD:Ref Document

Bid Value: Ref Document

130 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Interferon Beta 1A Exclusively For Subcutaneous Use Atc L03Ab07 For The Period 01 11 2024 31 10 2026

Deadline: 05 Sep 2026

Germany

Ref. No.: 8798282

EMD:Ref Document

Bid Value: Ref Document

130 Days Left

Craft Services In Construction

Deadline: 05 Jul 2028

Sweden

Ref. No.: 8797100

EMD:Ref Document

Bid Value: Ref Document

799 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Filgotinib L04Af04 Within The Framework Of A So Called Open House Model

Deadline: 31 Aug 2026

Germany

Ref. No.: 8796348

EMD:Ref Document

Bid Value: Ref Document

125 Days Left

Open House Drug Rebate Agreements Sorafenib Atc L01Ex02

Deadline: 05 Sep 2026

Germany

Ref. No.: 8793928

EMD:Ref Document

Bid Value: Ref Document

130 Days Left

Open House Drug Discount Agreements Naproxen Atc M01Ae02

Deadline: 05 Sep 2026

Germany

Ref. No.: 8793766

EMD:Ref Document

Bid Value: Ref Document

130 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Filgrastim L03Aa02 Within The Framework Of A So Called Open House Model

Deadline: 31 Aug 2026

Germany

Ref. No.: 8791885

EMD:Ref Document

Bid Value: Ref Document

125 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Golimumab L04Ab06 Within The Framework Of A So Called Open House Model

Deadline: 31 Aug 2026

Germany

Ref. No.: 8791055

EMD:Ref Document

Bid Value: Ref Document

125 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Erythropoietin B03Xa01 Within The Framework Of A So Called Open House Model

Deadline: 31 Aug 2026

Germany

Ref. No.: 8789001

EMD:Ref Document

Bid Value: Ref Document

125 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Olanzapine N05Ah03 Without Solid Oral Dosage Forms As Part Of A So Called Open Hou

Deadline: 31 Aug 2026

Germany

Ref. No.: 8788988

EMD:Ref Document

Bid Value: Ref Document

125 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Sultiam N03Ax03 Only Film Coated Tablets Within The Framework Of A So Called Open

Deadline: 31 Aug 2026

Germany

Ref. No.: 8788968

EMD:Ref Document

Bid Value: Ref Document

125 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Lanreotide Atc H01Cb03 Obo For The Period 01 11 2024 31 10 2025 Plus Extension Option 1X12 Months

Deadline: 05 Sep 2026

Germany

Ref. No.: 8788391

EMD:Ref Document

Bid Value: Ref Document

130 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Clobetasol D07Ad01 Within The Framework Of A So Called Open House Model

Deadline: 31 Aug 2026

Germany

Ref. No.: 8785935

EMD:Ref Document

Bid Value: Ref Document

125 Days Left

Showing 7936 to 7950 of 8325 results

Discover Tenders by Modelling Pastes Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Modelling Pastes Sector

Filter Your Search

FREE Trial plan for all new users!